-
公开(公告)号:US20200157110A1
公开(公告)日:2020-05-21
申请号:US16626254
申请日:2018-06-22
Inventor: Chunhao YANG , Linghua MENG , Haoyue XIANG , Jing LI , Xi ZHANG , Xiang WANG , Cun TAN , Qian HE , Jian DING , Yi CHEN
IPC: C07D487/04 , C07D519/00
Abstract: The present disclosure relates to 7-substituted pyrrolo[2,1-f][1,2,4]triazine compounds or pharmaceutically acceptable salts thereof, and preparation methods and uses thereof. These compounds show good PI3K inhibitory activity, can effectively inhibit the activity of PI3K kinase, and has significant enhancement and improvement of pharmacokinetic properties, such as bioavailability, due to the introduction of the 7-position group; furthermore, the compounds of the present disclosure exhibit an unpredictable high selectivity and strong inhibitory activity on PI3Kδ, and thus these compounds can be used for treating diseases related to PI3K pathway, especially for anti-cancer or for the treatment of tumors, leukemias and autoimmune diseases. After further optimizing and screening, the compounds are expected to be developed into a new type of anti-tumor drugs.
-
公开(公告)号:US20200172502A1
公开(公告)日:2020-06-04
申请号:US16623297
申请日:2018-05-31
Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES , FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD.
Inventor: Chunhao YANG , Zehong MIAO , Cun TAN , Xiajuan HUAN , Jian DING , Yi CHEN
IPC: C07D307/84
Abstract: Disclosed are a 2-[4-(methylaminomethyl)phenyl]-5-fluoro-benzofuran-7-carboxamide hydrochloride polymorph, a preparation method therefor and an application thereof. Specifically, disclosed are three crystalline forms, i.e., crystalline forms A, B, and C, of 2-[4-(methylaminomethyl)phenyl]-5-fluoro-benzofuran-7-carboxamide hydrochloride (formula I), preparation methods for the three crystalline forms, and use of the three crystalline forms in preparation of drugs.
-